Augustine M.K. Choi

Acute Respiratory Distress Syndrome - 2nd edition, illustrated, revised - London CRC Press 2016 - 476 pages - Volume 233 of Lung Biology in Health and Disease .

Contents:

Chapter 1 Definitions and Clinical Risk Factors

A Public Health Perspective

Chapter 3 Radiographic Findings of the Acute Respiratory Distress Syndrome

Chapter 4 Pulmonary Pathology of ARDS Diffuse Alveolar Damage

Experimental Studies

Clinical Studies

Chapter 7 Apoptosis in the Pathogenesis and Resolution of Acute Lung Injury

Chapter 8 Pathogenesis of VentilatiorInduced Lung Injury

Mechanisms and Relationship to Clinical Acute Lung Injury

Role of the Endothelial Cytoskeleton

Chapter 16 Surfactant Therapy in the Acute Respiratory Distress Syndrome

Chapter 17 Prone Position in ARDS

Chapter 18 Mechanical Ventilation in the Acute Respiratory Distress Syndrome

Chapter 19 Fluid Therapy and Hemodynamic Monitoring in Acute Lung Injury

Chapter 20 Pathogenesis of Sepsis and SepsisInduced Acute Lung Injury

Chapter 21 CellBased Therapy for Acute Lung Injury and Acute Respiratory Distress Syndrome

Treatment Implications

Chapter 10 TransfusionRelated Acute Lung Injury

Chapter 11 Mechanisms of Fibroproliferation in Acute Lung Injury

Chapter 12 Current Approaches and Recent Advances in the Genetic Epidemiology of Acute Lung InjuryAcute Respiratory Distress Syndrome

Chapter 13 Gene Expression Profiling and Biomarkers in ARDS

Chapter 22 Chemokines and Cytokines in ARDS

Index

Back Cover


The only available text to focus primarily on Acute Respiratory Distress Syndrome (ARDS).Thoroughly revised content and ten new chapters provide pulmonologists with the latest developments and applications of pharmacological and mechanical therapies needed to treat the debilitating and difficult condition of ARDS.Highlights include:the definition,

1420088416 9781420088410 = actin activation acute lung injury acute respiratory distress adult airspaces ALI/ARDS alveolar alveolar epithelial cells apoptosis Appl Physiol ARDS ARDS patients artery associated blood catheter Cell Mol Physiol chemokines Chest clinical trial cm H2O coworkers critically ill patients cytokines cytoskeleton decreased disease effects endothelial cells endothelium epithelium fibrosis fluid clearance function gene expression genetic growth factor human increased induced infection inflammation inhibition integrin kinase lavage leukocytes levels Lung Cell Mol lung volume macrophages Matthay mechanical ventilation mediators membrane mesenchymal stem cells mice mL/kg models mortality MSCs neutrophil outcome oxygenation pathogenesis pathways patients with acute patients with ARDS PEEP permeability Physiol Lung Cell plasma platelets pneumonia potential proinflammatory prone position pulmonary edema rats receptor Respir Crit respiratory distress syndrome respiratory failure Rev Respir risk role sepsis septic shock severe sepsis signaling strategy studies therapy tidal volume tissue TRALI transfusion vascular ventilator-induced vivo

--Medical / Pulmonary & Thoracic Medicine-- Medical / General --Medical / Critical Care-- Medical › General --Respiratory Distress Syndrome, Adult.--Systemic Inflammatory Response Syndrome.

RC776.R38A2795 2009 W1 LU62 v.233 2009 / WF 140 A183453 2009

616.24 CHO